Green Thumb Industries
Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Green Thumb Industries earns a Neutral rating with a composite score of 59.83, reflecting a company delivering operational excellence in fundamentals yet facing muted market visibility and minimal editorial momentum. The operator demonstrates textbook execution on the pillar that matters most: its fundamentals subscore registers 77.38, anchored by an 87.4 operating-margin subscore and an 80.2 gross-margin subscore that confirm disciplined cost management and pricing power. Positive EBITDA generation eliminates balance-sheet risk, while the market-cap tier subscore of 87.7 places the firm comfortably among the sector's larger players. Revenue expansion has moderated—reflected in a 57.4 revenue-growth subscore—but margin integrity more than compensates, positioning the company to convert top-line stability into sustained profitability.
Regulatory conditions remain supportive, with a 73.0 pillar score driven by an 80.0 jurisdiction subscore tied to Canadian domicile and zero enforcement hits over the trailing six months. Filing cadence lands at 62.5, indicating steady but unremarkable disclosure rhythm. The weakness lies elsewhere: market and editorial pillars score 40.0 and 30.0, respectively, signaling absent price discovery and negligible newsroom attention. Without tradable equity quotes or media catalysts, investor sentiment remains dormant despite strong operational performance.
The critical variable is whether Green Thumb can catalyze market liquidity or trigger editorial coverage through a liquidity event, strategic transaction, or material operational disclosure that bridges the gap between private execution and public recognition.
- Headquarters
- 325 WEST HURON STREET, SUITE 700, CHICAGO, IL, 60654
- Phone
- 312-471-6720
- Auditor
- as stated in their attestation report
- SEC CIK
- 1795139
- Website
- Company website
- Market cap
- $1.56B
- Enterprise value
- $1.77B
- P/E ratio
- 13.9
- PEG ratio
- 1.79
- Price to book
- 0.82
- Price to sales
- 1.30
- EV / EBITDA
- 3.48
- Revenue (TTM)
- $1.20B
- Gross profit (TTM)
- $575.3M
- EBITDA
- $284.4M
- Operating margin
- 13.6%
- Profit margin
- 10.1%
- Rev growth YoY
- 7.4%
- Return on equity
- 6.6%
- Return on assets
- 3.1%
- EPS (TTM)
- $0.51
- EPS est. current year
- $0.12
- Wall St. target price
- $15.67
- Shares outstanding
- 195.1M
- Insider ownership
- 1.9%
- Institutional ownership
- 8.2%
- Beta
- 0.93
- Full-time employees
- 4,900
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEDAR+
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Green Thumb Industries (GTBIF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Green Thumb Industries (GTBIF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, insider selling. (2 bullish signals, 3 bearish signals.)
Vertically integrated MSO operating in 15 markets. Known for premium brands (RYTHM, Dogwalkers, Beboe) and strong margins.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for GTBIF are maintained by Cannabis Investor News and refreshed throughout the trading day.